Alimera Sciences Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ALIMERA SCIENCES INC, and when can generic versions of ALIMERA SCIENCES INC drugs launch?
ALIMERA SCIENCES INC has two approved drugs.
There are two US patents protecting ALIMERA SCIENCES INC drugs.
There are one hundred and fifty-six patent family members on ALIMERA SCIENCES INC drugs in twenty-seven countries and two supplementary protection certificates in two countries.
Summary for Alimera Sciences Inc
International Patents: | 156 |
US Patents: | 2 |
Tradenames: | 2 |
Ingredients: | 1 |
NDAs: | 2 |
Drugs and US Patents for Alimera Sciences Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alimera Sciences Inc | YUTIQ | fluocinolone acetonide | IMPLANT;INTRAVITREAL | 210331-001 | Oct 12, 2018 | RX | Yes | Yes | 7,998,108 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Alimera Sciences Inc | YUTIQ | fluocinolone acetonide | IMPLANT;INTRAVITREAL | 210331-001 | Oct 12, 2018 | RX | Yes | Yes | 8,871,241 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Alimera Sciences Inc | ILUVIEN | fluocinolone acetonide | IMPLANT;INTRAVITREAL | 201923-001 | Sep 26, 2014 | RX | Yes | Yes | 8,871,241 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Alimera Sciences Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Alimera Sciences Inc | YUTIQ | fluocinolone acetonide | IMPLANT;INTRAVITREAL | 210331-001 | Oct 12, 2018 | 9,849,085 | ⤷ Sign Up |
Alimera Sciences Inc | ILUVIEN | fluocinolone acetonide | IMPLANT;INTRAVITREAL | 201923-001 | Sep 26, 2014 | 6,217,895 | ⤷ Sign Up |
Alimera Sciences Inc | ILUVIEN | fluocinolone acetonide | IMPLANT;INTRAVITREAL | 201923-001 | Sep 26, 2014 | 8,252,307 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Alimera Sciences Inc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Denmark | 1592407 | ⤷ Sign Up |
Denmark | 1696822 | ⤷ Sign Up |
Cyprus | 1114947 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Alimera Sciences Inc Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2233112 | 132014902285293 | Italy | ⤷ Sign Up | PRODUCT NAME: FLUOCINOLONE ACETONIDE(ILUVIEN); AUTHORISATION NUMBER(S) AND DATE(S): 042616019, 20140530;PL27813/0001, 20120504 |
2233112 | 122014000063 | Germany | ⤷ Sign Up | PRODUCT NAME: FLUOCINOLONACETONID; NAT. REGISTRATION NO/DATE: 82809.00.00 20120720; FIRST REGISTRATION: GB PL 27813/0001 20120504 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.